Not Verified

Binaytara Implementation Science Research Awards

Binaytara

The Binaytara Implementation Science Research Award supports investigators focused on improving how evidence-based cancer care is delivered in real-world settings. This award is aligned with the Summit on Cancer Health Disparities (SCHD) and prioritizes projects that address access, equity, and delivery gaps across diverse populations.

Award Amount: Up to $25,000 per project

Award Focus

Projects should address:

Implementation of evidence-based cancer care
Barriers to access, adoption, or sustainability
Health disparities and equity-driven interventions
Real-world cancer care delivery in clinical or community settings

Application Pathway

1. Abstract Submission (via SCHD)

Applicants must submit an abstract based on completed or ongoing research for presentation at the Summit on Cancer Health Disparities.

Call for abstracts are OPEN > Apply Here

2. Research Proposal

Authors of accepted abstracts are invited to submit a separate implementation science research proposal.

Only early-career hematology/oncology faculty (3 years or less) or fellows are eligible for the research award funding.
The proposal may be related to the submitted abstract or a different research.
Limit one proposal per person.

3. Impact Pitch at SCHD

Finalists present their proposals live during the Impact Pitch session held as part of SCHD.

Funding and Expectations

Competitive research funding of up to $25,000 per project
No institutional overhead or indirect costs
Funds must be used solely for project-related expenses
Acknowledgment of Binaytara support is required
Awardees present progress or outcomes at a future SCHD meeting

AI Based Application Success Predictor

Binaytara Foundation is a nonprofit organization supporting cancer research, oncology education, and improvements in access to cancer care. Its research awards generally support early-career hematology/oncology faculty and fellows, with awards of up to $25,000–$50,000, depending on the program. A distinctive feature is its live Impact Pitch: Research Award Challenge, where finalists present their proposals to expert reviewers and answer questions.

Binaytara

These predictors are a reviewer-oriented assessment based on Binaytara’s published program descriptions, eligibility rules, and proposal-selection process—not a claim that the organization publishes a numerical scoring rubric.

Top 10 grant success predictors

Ranked by likely importance across Binaytara research awards. The exact priorities vary by award program.

1

★★★★★

Strong alignment with the specific award

The proposal must fit the award’s purpose: lung cancer, precision oncology, hematologic malignancies, or implementation science and cancer health disparities. A strong project in the wrong program may be less competitive than a tightly aligned project.

Binaytara

2

★★★★★

High clinical impact and a meaningful unmet need

Explain the cancer-care problem, who is affected, what current practice fails to address, and how the project could improve diagnosis, treatment, outcomes, or care delivery.

3

★★★★★

Innovation and a clear differentiator

Present a new hypothesis, therapeutic strategy, diagnostic approach, precision-medicine method, or care-delivery solution. State explicitly what is new compared with current evidence and practice.

4

★★★★★

Scientific rigor and methodological quality

Use clear objectives, appropriate study design, defensible measures and analysis, relevant controls, and a credible plan for interpreting results. Implementation projects should measure whether evidence-based care is adopted, delivered, or sustained—not only whether an intervention was proposed.

5

★★★★☆

Feasibility and achievable milestones

Show that the project can be completed with the requested funds and within the award period. Specify recruitment, data access, resources, key milestones, risks, and contingency plans.

6

★★★★☆

Applicant promise and early-career development

Binaytara’s research awards are designed for early-career researchers. Demonstrate ownership of the project, relevant expertise, a credible development trajectory, and how the award will help establish future research capability.

Binaytara

7

★★★★☆

Equity and real-world relevance, where applicable

For implementation-science awards, address real barriers to access, adoption, quality, or sustainability of cancer care, especially disparities affecting underserved populations. This is a central program fit, not merely an optional diversity statement.

binaytara.org

8

★★★★☆

Clear pathway to patient benefit or clinical translation

Describe how findings could influence a future trial, clinical decision, diagnostic pathway, treatment strategy, or scalable care-delivery intervention. Avoid promising immediate clinical impact if the project is exploratory.

9

★★★☆☆

A compelling live pitch and strong responses to questions

The Impact Pitch format makes communication important. Explain the problem, innovation, methods, expected results, and impact in plain language. Be ready to defend feasibility, limitations, costs, and the next steps.

binaytara.org

10

★★★☆☆

Eligibility and a complete, compliant application

Meet the relevant career-stage and award-specific requirements, follow the abstract-to-proposal pathway where required, and provide a clear budget. Some awards require an accepted conference abstract and restrict eligibility to its first author.

Specialties

Cancer

Oncology

Hematology

Eligibility Requirements

First authors of accepted abstracts, AND
Early-career faculty or Hematology/Oncology or related subspecialty fellows

Sponsor Details

Sponsor Institute/Organizations: Binaytara

Sponsor Type: Corporate/Non-Profit

Address: 3380 146th Pl SE, Suite 340 Bellevue, WA 98007

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity